PHARMA LITERATI

Smt. Kishoritai Bhoyar College of Pharmacy and APTI are organizing 9th Pharma Festival, National level Dance Competition "Kshitij: 2014-15". The details are as follows: Theme:                Kshitij: Endless limit to success Dates:                 2nd February 2015. Organized by:     APTI and Smt. Kishoritai Bhoyar College of Pharmacy .     Location:            Nagpur, India. Details available at: http://www.aptims.org/writereaddata/PDF/Pharma-Fest.pdf

Innovare Academics Sciences is organizing 1 st International Conference on Novel Frontiers in Pharmaceutical & Health Sciences (INNOPHARM 1).   INNOPHARM 1 will feature leading international speakers and bring together researchers, academicians, Pharma industrialist, healthcare professionals, healthcare technology providers, Pharmacists and experts of various pharmaceutical fields from all over the world to discuss and share novel frontiers in pharmaceutical and health sciences.   The details are as follows: Theme:     International Conference on Novel Frontiers in Pharmaceutical & Health Sciences . Dates:                 10th -11th October 2015. Organized by:     Innovare Academics Sciences .     Location:            Minal Campus, Ayodhya Bypass Road, Bhopal 462041 MP, India   Details available at: http://innopharm1.innovareacademics.in/  

Dear All, Every week of thousands of patent applications are published in India. The patent applications filed by the academic research institutes in India go un-noticed.   We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes.   For details of these patents, please write back to us at pharmaliterati@gmail.com   Indian patent applications published on 23rd January 2015 Invention Application No Inventors Institute Compositions and methods for the treatment of cancer 3242/CHE/2013 A Rajesh Not known {Mettupalayam, Tamil Nadu.}  

Habil Khorakiwala, chairman,Wockhardt Group is the new Chancellor of Jamia Hamdard University, New Delhi. He spoke about his vision for the University, the gaps in the Indian higher education sector and the importance of hard work in a conversation with Prachi Rege of Zee News.   He highlighted that his focus would be to challenge the faculty to aim for excellence. He further stated that as a Chancellor, it will be his responsibility to give them a reality check of what they are doing and how relevant it is to things happening around them.     Detailed interview can be accessed at : http://zeenews.india.com/news/education/my-focus-will-be-to-challenge-the-faculty-to-aim-for-excellence-habil-khorakiwala_1532989.html

Dear All, Thanks a lot for your encouraging support that we have got 50 posts landmark crossed in a span of around 3 months. It is essential to mention that the bloggers are putting their all intellectual efforts to make this blog a success.   We would be more than pleased see the contribution from the authors as well. Also, request all the students, faculties and industry professionals to share the blog with their colleagues, friends and students.   Team Pharma Literati

The economic times reports that,  you may be able to buy nearly 500 low-cost drugs supplied by the government at your neighbourhood pharmacy from July under Jan Aushadhi brand if a plan proposed by an expert panel is implemented.   The drugs are likely to cost 50-95 per cent less than their private branded counterparts, members of the expert committee told ET, adding that the medicines selected under the scheme span six therapeutic categories including cardiovascular, diabetes, respiratory and antibiotics. Under this proposal, the government plans to start procuring from private players to resuscitate the fledgling Jan Aushadhi scheme which operates through a chain of brick-and-mortar stores and is completely dependent on the handful of public sector units for drug supply that makes it vulnerable to frequent stock-outs.     A limited portfolio of medicines coupled with chronic stock-outs has seriously eroded the credibility of these stores as customers desire a one-stop sho

The Telegraph reports that Piramal announced that it has invested USD 30.65 million towards acquiring Coldstream Laboratories Inc. (‘Coldstream’), through its wholly owned subsidiary in the USA in an all cash transaction.   Coldstream is a Contract Development and Manufacturing Organisation (CDMO) focused on the development and manufacturing of sterile injectable products. Coldstream was founded in 2007 and is majority owned by University of Kentucky Research Foundation (an affiliate of the University of Kentucky). Coldstream is a specialty pharmaceutical contract manufacturer with an emphasis on clinical trial to commercial-scale manufacturing of sterile liquid and lyophilized parenterals and injectables. Coldstream has developed differentiated expertise to formulate and manufacture high potency and cytotoxic compounds including Antibody Drug Conjugates (ADCs). The company operates from a FDA approved facility located in Lexington, Kentucky, USA.    Commenting on the acquis

The high cost of research and drug discovery has not deterred start-ups from entering the arena of drug discovery. As the economics times reports, start-ups like Bugworks, Vitas Pharma have entered the field of drug discovery.   Across geographies, big pharmaceutical companies seem to have stepped back from research and development (R&D) for new drug discovery in this field. That is simply because it's more profitable to find new drugs that focus on lifestyle and other diseases where efficacy isn't diminished by use. But a couple of startups in India have recently entered the field of drug discovery. Take for instance Bugworks in Bengaluru, co-founded by Anand Anandkumar, Janaki Venkatraman and Santanu Datta, and Vitas Pharma in Hyderabad, co-founded by Radha Rangarajan and Rajinder Kumar.    Please see the details at: http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/why-indian-startups-like-bugworks-vitas-pharma-have-entered-th

Associated Chambers of Commerce and Industry of India (ASSOCHAM) is organizing the Pharma Summit with the theme “Changing Dynamics the Road Ahead”, 18 th February, 2015, Hotel Le Meridien, New Delhi in association with Organization of Pharmaceutical Producers of India (OPPI), Indian Drug Manufacturers' Association (IDMA) and Confederation of Indian Pharmaceutical Industry (CIPI) and Indian Pharmaceutical Association (IPA). The details are as follows: Theme:                Changing dynamics, the road ahead . Dates:                 18th February 2015 . Organized by:     ASSOCHAM .   Location:              New Delhi. Details available at: http://www.assocham.org/eventdetail.php?id=1100

The news of Indian Institute of Packaging (IIP), an autonomous body under the Ministry of Commerce, taking up the matter of printing expiry dates behind each tablets, may have caused a flutter among the pharmaceutical companies because of the cost factor, there are positive reactions from the general public and print firms reports PrintWeek India.   “Printing of expiry dates of each pill will be impossible to carry out and we are not just talking about the cost factor and reading being difficult to decipher, printing it in red, along the length of the strip, preferable on either side, will be a good idea,” said one response.   At present, the expiry date is printed in one corner of the strip along with the batch number and date of manufacturing. But when Ahmedabad-based Zudus Cadilla sent in their entry of Inditel tablets for the IndiaStar 2014 event, with each pocket containing tablet printed with details of product name and expiry, IIP’s director, NC Saha saw this as an op

Despite significant price control on essential drugs across almost all therapy groups, sales by Indian manufacturers in December 2014 grew 14.4%  reports Mint.   India’s drug market grew 11% to touch Rs. 87,235.19 crore in the 13 months ended 31 December 2014 powered by local drug makers, data showed.   The IMS released data for December 2014 as well as for the 13 months from 1 December 2013 to 31 December 2014.   The top 10 drug makers accounted for 40% of sales in the 13-month period. Among the top 10 companies, Cipla Ltd grew 24%. Eighteen of its products are among the country’s 300 top-selling brands.   Anti-infection drugs constituted the biggest therapy segment, with a market share of 13.3% in December.   As per December’s moving annual turnover (MAT) Abbott Laboratories group maintained its top position in market share with a market share of 6.45%.   Among the top 25 companies, MSD Pharmaceuticals Pvt. Ltd, the Indian unit of US drug maker Merck and Co

Dear All, Every week of thousands of patent applications are published in India. The patent applications filed by the academic research institutes in India go un-noticed.   We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes.   For details of these patents, please write back to us at pharmaliterati@gmail.com   Indian patent applications published on 16th January 2015 Invention Application No Inventors Institute Formulation and evaluation of transdermal patch for Sildenafil citrate 2106/DEL/2013 A 1) Prof. S.S. Agrawal 2) Mr. Dheeraj Nagpal Amity University, Noida, Uttar Pradesh Formulation of pH sensitive mucoadhesive microspheres of omeprazole 2107/DEL/2013 A 1) Yogesh Singh Rathore 2) Jyoti Rathore

Dear All, Every week of thousands of patent applications are published in India. The patent applications filed by the academic research institutes in India go un-noticed.   We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes.   For details of these patents, please write back to us at pharmaliterati@gmail.com   Indian patent applications published on 9th January 2015 Invention Application No Inventors Institute A pharmaceutical composition for mucoadhesive microparticles in the delivery of therapeutic agents 6636/CHE/2014 A 1) Dr. Anna Balaji 2) Ms. Swapna Sirikonda Pathfinder institute of Pharmacy education & Research. Opp Airport, Besides Mamnoor Camp, Khammam Road, Werangal, Karnataka Novel fibrin nanoparticle

L M College Of Pharmacy is organizing two-days national conference on "Frontiers and avenues in the field of Herbal Drug Research." The details are as follows: Theme:               Frontiers and avenues in the field of Herbal Drug Research . Dates:                 6th and 7th February 2015 . Organized by:     Frontiers and avenues in the field of Herbal Drug Research .   Location:              Ahmedabad. Details available at: http://lmcp.in/yahoo_site_admin/assets/docs/LMCP_herbal_BROCHURE.336135927.pdf

Indian Patent Office has rejected a patent application for Sofosbuvir which was discovered by Pharmasset and developed by Gilead Sciences. Sofosbuvir is used against Hepatitis C. The patent application which was filed by Gilead covered the drug product which has been granted in several territories including US. The price of patented medicines has always been a concern for the Indian healthcare industry. With this decision, we can be rest assured that patients with Hepatitis C would have access to affordable treatment options. It is however worth noting that Indian companies like Cipla, Zydus, Hetero, Ranbaxy and others had entered into license agreements with Gilead to sell their product in India. Gilead had also planned to launch its own drug Sovaldi at the cost of 300USD per bottle. 

Vivekanand Education Society’s College Of Pharmacy is organizing one-day national seminar and poster competition on "Innovations in drug delivery: Trends, Opportunities and Regulatory Aspects." The details are as follows: Theme:               Innovations in drug delivery: Trends, Opportunities and Regulatory Aspects . Dates:                 24th January 2015 . Organized by:     Vivekanand Education Society’s College Of Pharmacy .   Location:              Mumbai. Details available at: http://www.vesip.org/u201_CInnovations_in_Drug_delivery_Trends_Opportunities_and_Regulatory_Aspects.pdf          

Sinhgad Technical Education Society's Sinhgad college of Pharmacy is organizing Savitribai Phule Pune University sponsored 4 different seminars at Pune. The details are as follows: 1. Theme: Lifecycle disorders: Avenues for Prophylaxis and Treatment Dates:  January 18 - 20, 2015 . 2. Theme: Current strategies in targeting Tyrosine Kinase for Anticancer Research Dates:  January 21- 22, 2015 . 3. Theme: The emerging threats of Dengue and Ebola Hemorrhagic Fever Dates:  January 28, 2015 . 4. Theme: New insights into current pharmacovigilence Dates:  January 29, 2015. Organized by: Sinhgad Technical Education Society's Sinhgad college of Pharmacy . Location: Pune. Details available at: http://www.sinhgad.edu/STES_Events_pdf_2015/SCOP/SCOP_Seminars_2015.pdf  

Asia’s Biggest & Nation’s most awaited healthcare summit & Awards organized by healthcare communication leader Pharmaleaders, the 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014 held in Mumbai on 26th December 2014 at Hotel Sahara Star, Mumbai, India.   The winners are as follows: Category Winner Organization India’s Most Admired Diabetologist 2014 Prof. (Dr) V.Mohan CMD &  Chief Diabetologist, Dr. Mohan's Diabetes Specialties Centre Healthcare Economist of the Year 2014 Dr Sanjeev Kanoria Vice Chairman Austrian Anadi Bank AG & Chairman, Advinia Healthcare Ltd.  Visionary Entrepreneur of the Year 2014 Mr. Dilip Surana CMD, Microlabs Ltd.  India’s Most Promising Orthopedic Surgeon Dr. Chandrasekar Chikkamuniyappa CEO  & Senior Joint Replacement Surgeon,  People Tree Hospitals India's Most Promising Entr